Exeter diabetes professor appointed as Editor-in-Chief of prestigious journal
A renowned expert in diabetes research will lead the future of research dissemination in Diabetes UK’s flagship journal.
Professor Noel Morgan, Emeritus professor of Endocrine Pharmacology at the University of Exeter Medical School, will assume his role as Editor-in-Chief of Diabetic Medicine from Tuesday 1 July 2025.
Diabetic Medicine focuses on disseminating research on all aspects of diabetes to improve the management of people with the condition, and Professor Morgan will take over from Professor Nick Oliver of Imperial College London who led the editorial team of Diabetic Medicine journal in the last four years.
Noel was conferred Emeritus status at the University of Exeter in 2024 and served as the Director of the Institute of Biomedical & Clinical Science in Exeter for 13 years. His illustrious 45-year research career has yielded significant breakthrough in Type 1 diabetes treatment. This includes the emergence of new clinical trials of anti-viral agents in treating viral infection after diabetes occurs in children.
Professor Morgan said: “I’m honoured and delighted to have been offered the opportunity to serve as the next Editor-in-Chief of Diabetic Medicine. The journal is recognised as a jewel in the crown of Diabetes UK, and it is a privilege to be entrusted to lead its exceptional editorial team. I’m excited to ensure that Diabetic Medicine is seen as a natural home for papers reporting the highest quality and most impactful research in the diabetes field across the globe”.
Noel has published more than 200 peer reviewed papers on diabetes research, and he also holds a Lifetime achievement award by the Network of Pancreatic Organ Donors with Diabetes (nPOD) for his contributions to diabetes research and treatment.
Dr Elizabeth Robertson, Director of Research and Clinical at Diabetes UK, said: “We are delighted to welcome Professor Noel Morgan as the new Editor-in-Chief of Diabetic Medicine, and extend our sincere thanks to Professor Nick Oliver for his outstanding leadership over the past four years. Under Professor Oliver’s guidance, the journal has grown significantly in both reach and impact, and we are deeply grateful for his dedication and service.
“Professor Morgan brings extensive expertise in diabetes and a strong commitment to advancing high-quality research, which will be invaluable as we continue to strengthen the journal’s contribution to the field. We warmly thank him for his longstanding and unwavering support of Diabetes UK.”
